Médica Sur S.A.B. de C.V (MEDICAB) - Net Assets

Latest as of December 2025: MX$2.52 Billion MXN ≈ $145.18 Million USD

Based on the latest financial reports, Médica Sur S.A.B. de C.V (MEDICAB) has net assets worth MX$2.52 Billion MXN (≈ $145.18 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$4.78 Billion ≈ $274.90 Million USD) and total liabilities (MX$2.25 Billion ≈ $129.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Médica Sur S.A.B. de C.V asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets MX$2.52 Billion
% of Total Assets 52.81%
Annual Growth Rate 6.75%
5-Year Change -48.67%
10-Year Change -23.73%
Growth Volatility 14.26

Médica Sur S.A.B. de C.V - Net Assets Trend (2000–2025)

This chart illustrates how Médica Sur S.A.B. de C.V's net assets have evolved over time, based on quarterly financial data. Also explore how large is Médica Sur S.A.B. de C.V's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Médica Sur S.A.B. de C.V (2000–2025)

The table below shows the annual net assets of Médica Sur S.A.B. de C.V from 2000 to 2025. For live valuation and market cap data, see market value of Médica Sur S.A.B. de C.V.

Year Net Assets Change
2025-12-31 MX$2.52 Billion
≈ $145.18 Million
+7.62%
2024-12-31 MX$2.34 Billion
≈ $134.90 Million
+15.06%
2023-12-31 MX$2.04 Billion
≈ $117.24 Million
-19.23%
2022-12-31 MX$2.52 Billion
≈ $145.16 Million
-48.67%
2021-12-31 MX$4.91 Billion
≈ $282.82 Million
+22.59%
2020-12-31 MX$4.01 Billion
≈ $230.71 Million
+8.86%
2019-12-31 MX$3.68 Billion
≈ $211.93 Million
+3.97%
2018-12-31 MX$3.54 Billion
≈ $203.83 Million
+2.75%
2017-12-31 MX$3.45 Billion
≈ $198.36 Million
+4.21%
2016-12-31 MX$3.31 Billion
≈ $190.35 Million
+1.97%
2015-12-31 MX$3.24 Billion
≈ $186.66 Million
+4.38%
2014-12-31 MX$3.11 Billion
≈ $178.84 Million
+12.68%
2013-12-31 MX$2.76 Billion
≈ $158.70 Million
+6.56%
2012-12-31 MX$2.59 Billion
≈ $148.93 Million
+19.10%
2011-12-31 MX$2.17 Billion
≈ $125.05 Million
+15.63%
2010-12-31 MX$1.88 Billion
≈ $108.15 Million
+9.52%
2009-12-31 MX$1.72 Billion
≈ $98.75 Million
+11.27%
2008-12-31 MX$1.54 Billion
≈ $88.75 Million
+9.19%
2007-12-31 MX$1.41 Billion
≈ $81.28 Million
+16.48%
2006-12-31 MX$1.21 Billion
≈ $69.78 Million
+17.79%
2005-12-31 MX$1.03 Billion
≈ $59.24 Million
+14.27%
2004-12-31 MX$900.86 Million
≈ $51.84 Million
+16.62%
2003-12-31 MX$772.45 Million
≈ $44.45 Million
+17.09%
2002-12-31 MX$659.71 Million
≈ $37.97 Million
+20.84%
2001-12-31 MX$545.95 Million
≈ $31.42 Million
+10.81%
2000-12-31 MX$492.70 Million
≈ $28.36 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Médica Sur S.A.B. de C.V's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 6629.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings MX$1.96 Billion 77.91%
Other Components MX$556.97 Million 22.09%
Total Equity MX$2.52 Billion 100.00%

Médica Sur S.A.B. de C.V Competitors by Market Cap

The table below lists competitors of Médica Sur S.A.B. de C.V ranked by their market capitalization.

Company Market Cap
Xiwang Foodstuffs Co Ltd
SHE:000639
$320.65 Million
Orascom Development Holding AG
SW:ODHN
$320.65 Million
Gran Tierra Energy Inc
TO:GTE
$320.71 Million
SmartCraft ASA
OL:SMCRT
$320.74 Million
Phihong Technology Co Ltd
TW:2457
$320.51 Million
Tianyu Ecology & Landscape Co
SHG:603717
$320.13 Million
Pengana Private Equity Trust
AU:PE1
$320.11 Million
RoadMain T Co Ltd
SHG:603860
$320.04 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Médica Sur S.A.B. de C.V's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,343,039,000 to 2,521,726,000, a change of 178,687,000 (7.6%).
  • Net income of 540,249,000 contributed positively to equity growth.
  • Dividend payments of 147,024,000 reduced retained earnings.
  • Share repurchases of 217,074,000 reduced equity.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income MX$540.25 Million +21.42%
Dividends Paid MX$147.02 Million -5.83%
Share Repurchases MX$217.07 Million -8.61%
Other Changes MX$2.54 Million +0.1%
Total Change MX$- 7.63%

Book Value vs Market Value Analysis

This analysis compares Médica Sur S.A.B. de C.V's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.21x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 MX$27.95 MX$61.00 x
2018-12-31 MX$28.72 MX$61.00 x
2019-12-31 MX$29.87 MX$61.00 x
2020-12-31 MX$32.51 MX$61.00 x
2021-12-31 MX$39.85 MX$61.00 x
2022-12-31 MX$23.36 MX$61.00 x
2023-12-31 MX$21.27 MX$61.00 x
2024-12-31 MX$24.47 MX$61.00 x
2025-12-31 MX$27.61 MX$61.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Médica Sur S.A.B. de C.V utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 21.42%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 11.28%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 1.89x
  • Recent ROE (21.42%) is above the historical average (14.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 11.06% 6.18% 0.61x 2.92x MX$3.68 Million
2001 13.36% 10.57% 0.70x 1.81x MX$18.36 Million
2002 15.83% 13.24% 0.73x 1.63x MX$38.47 Million
2003 14.54% 13.24% 0.71x 1.55x MX$35.08 Million
2004 14.64% 14.02% 0.68x 1.54x MX$41.75 Million
2005 14.04% 13.66% 0.68x 1.51x MX$41.53 Million
2006 16.02% 15.86% 0.72x 1.40x MX$72.97 Million
2007 15.32% 15.63% 0.70x 1.41x MX$75.07 Million
2008 12.56% 12.55% 0.63x 1.58x MX$39.49 Million
2009 13.80% 13.37% 0.63x 1.64x MX$65.21 Million
2010 12.31% 12.82% 0.64x 1.49x MX$43.39 Million
2011 10.31% 11.79% 0.63x 1.39x MX$6.79 Million
2012 11.61% 14.38% 0.62x 1.30x MX$41.78 Million
2013 13.77% 16.83% 0.68x 1.21x MX$104.05 Million
2014 11.24% 15.23% 0.63x 1.17x MX$38.40 Million
2015 7.43% 10.58% 0.60x 1.16x MX$-83.26 Million
2016 4.32% 5.51% 0.47x 1.65x MX$-187.69 Million
2017 6.73% 6.76% 0.61x 1.63x MX$-112.79 Million
2018 4.78% 4.69% 0.66x 1.54x MX$-184.78 Million
2019 3.82% 3.80% 0.63x 1.59x MX$-227.60 Million
2020 13.94% 12.51% 0.71x 1.57x MX$158.04 Million
2021 23.50% 29.56% 0.56x 1.42x MX$663.18 Million
2022 37.67% 24.56% 0.85x 1.82x MX$697.67 Million
2023 31.18% 15.38% 1.00x 2.03x MX$431.36 Million
2024 19.70% 10.48% 1.00x 1.88x MX$227.21 Million
2025 21.42% 11.28% 1.00x 1.89x MX$288.08 Million

Industry Comparison

This section compares Médica Sur S.A.B. de C.V's net assets metrics with peer companies in the Medical Care Facilities industry.

No peer company data available for comparison.

About Médica Sur S.A.B. de C.V

MX:MEDICAB Mexico Medical Care Facilities
Market Cap
$320.61 Million
MX$5.57 Billion MXN
Market Cap Rank
#14689 Global
#106 in Mexico
Share Price
MX$61.00
Change (1 day)
+0.00%
52-Week Range
MX$36.25 - MX$62.00
All Time High
MX$62.00
About

Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; gastroenterology, hepatology, and endoscopy; general surgery; geriatric; and gynecology and obstetrics services. It also provides specialized sur… Read more